Equity
€72,785 ▼ 41.7%
DR MORERE paid out €75,000 in dividends. That is 328% of the 2025 profit.
DR MORERE
Lifetime
6 annual accounts with figures on one time axispeak €118,863 (2024)
€34,908▼ 70.6%
peak €85,983 (2024)
€22,851▼ 73.4%
peak €149,951 (2023)
€72,785▼ 41.7%
€153,214▲ 3.8%
Board1 name since 2019
1 director
Documentsfilings and deeds
15-10-202676 days late
2025micro format
Gross margin from €118,863 to €34,908Result from €85,983 to €22,851Dividend €75,000Equity from €124,934 to €72,785Investments €57,127Cash from €34,688 to €8,210
Key points
from the 2025 annual accountsResult
€22,851 ▼ 73.4%
The result fell in 2025 from €85,983 to €22,851.
Investments
€73,085 15.5 × depreciation
Green is investment, beige is depreciation.
2025 accounts filed 76 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as DR MORERE has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for DR MORERE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0737795559
Registered office moved from Etterbeek to Woluwe-Saint-Lambert
New registered office: avenue Jean Laudy 14 à 1200 Woluwe-Saint-Lambert · Previous registered office: rue Capitaine Joubert 32/4 à 1040 Etterbeek · General meeting of 16-03-2022 · Gazette deed
Incorporation
Founder: (comparant) · 50 shares · Appointment: (director) · published on 20-11-2019 · Gazette deed
First establishment
Kapitein Joubertstraat 32, Etterbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR MORERE Woluwe-Saint-Lambert | €225,999 | €34,908 | 32.2% | - |
| MJ Orthopedics Watermael-Boitsfort | €176,028 | €35,605 | 57.3% | - |
| PHYSIOMEGA Mettet | €289,914 | €39,648 | 35.5% | - |
| FANCELLO MEDIC La Louvière | €211,437 | €37,577 | 55.2% | - |
| CD MEDICALE Chaudfontaine | €185,233 | €41,447 | 4.3% | - |
| 2 QURATIO Sint-Truiden | €182,730 | €31,215 | 21.7% | 0 |
| DERMASKIN MEDICAL Woluwe-Saint-Lambert | €270,559 | €49,432 | -1.0% | - |
These companies have the same main activity as DR MORERE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €176,000 and €290,000, founded between 2018 and 2021.
Official details
Source: KBO- Status
- Active since 18-11-2019Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.296.046.7151040 Etterbeek, since 18-11-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Insights on DR MORERE
DR MORERE files the micro format. That format states no turnover. The gross margin rose from €18,988 in 2020 to €34,908 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR MORERE
- What is the company number of DR MORERE?
- The company number of DR MORERE is 0737.795.559. The VAT number is the same number with BE in front: BE 0737.795.559.
- Where is DR MORERE based?
- The registered office is at Jean Laudylaan 14, 1200 Woluwe-Saint-Lambert.Company details
- What does DR MORERE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR MORERE?
- DR MORERE is a private limited company (BV).
- When was DR MORERE founded?
- DR MORERE was founded on 18-11-2019.
- Is DR MORERE still active?
- Yes, DR MORERE is an active enterprise in the KBO register.
- What is the turnover of DR MORERE?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €34,908 and 48 comparable companies (NACE 86). It probably lies between €79,000 and €150,000.Financials
- Is DR MORERE profitable?
- In financial year 2025, DR MORERE made a profit of €22,851.
- Where can I find the annual accounts of DR MORERE?
- DR MORERE filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR MORERE due?
- DR MORERE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.